Mid-Year Report — AMERICAN SOCIETY OF HEALTH-SYSTEM PHARM… for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARM… (2007)

Firm

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Client

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Income

—

Expenses

$60,000

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medication error reporting; cost-effectiveness of medications; FDA appropriations; comparative effectiveness research; counterfeit drugs; Prescription Drug User Fee Act reauthorization; direct-to-consumer advertising;

Lobbyist	Covered position, as disclosed
MARA BAER	—
JUSTINE COFFEY	N/A
BRIAN M MEYER	N/A
MARIA D SPENCER	N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Medicare Part D Implementation; Deficit Reduction Act Implementation; Payment formulas for Part B, outpatient and inpatient prospective payment systems; 340B drug pricing program; Payment for pharmacist services

Lobbyist	Covered position, as disclosed
MARA BAER	—
JUSTINE COFFEY	N/A
BRIAN M MEYER	N/A
MARIA D SPENCER	N/A

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Pharmacy PHA

Pharmacy compounding; Drug safety and post-marketing surveillance; Medication therapy management programs; Restricted drug distribution systems; Prescription Drug User Fee Act reauthorization; Minimum effective doses; Prohibiting re-use of brand names; Generic biologics

Lobbyist	Covered position, as disclosed
MARA BAER	—
JUSTINE COFFEY	N/A
BRIAN M MEYER	N/A
MARIA D SPENCER	N/A

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.